Role at ANSTO
Showing 161 - 176 of 176 results
An accurate and inexpensive test for Malaria just around the corner
After your experiment
Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.
ANSTO recognises scientific achievement, leadership, external collaboration and outreach at Awards event
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
Role at ANSTO
Improved understanding of progression rates in Parkinson’s and Alzheimer’s disease, and schizophrenia
Statement of Intent
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
COVIDSafe Plan Victoria
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.
Nuclear techniques reveal 'stone age': dating kidney stones
ANSTO recognises the contribution of staff for outstanding work, innovation, and excellence
ANSTO announces the recipients of the 2022 organisational awards
A closer look at the science of detecting flu
Role at ANSTO
Beamtime guide - Imaging and Medical
Information has been provided to assist with the preparation of experiment proposals and beamtime.
Deuteration Publications
Publications by ANSTO's National Deuteration Facility.
Samples - Infrared microspectroscopy
The Infrared microspectroscopy microscopes can record spectra from a range of different samples; from thin microtomed sections to polished blocks and embedded particles. This section highlights the types of samples that can be analysed using the IRM beamline
High Performance Macromolecular Crystallography Beamline (MX3)
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.